Advertisement
CPAY vs HCAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPAY is a Hold and HCAT is a Hold.
CPAY saw its Stochastic Oscillator leaves the overbought zone
The Stochastic Oscillator for CPAY moved out of overbought territory on October 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 56 similar instances where the indicator exited the overbought zone. In 38 of the 56 cases the stock moved lower. This puts the odds of a downward move at 68%.
Technical Analysis (Indicators)
Bearish Trend Analysis
CPAY moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CPAY crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for CPAY entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CPAY as a result. In 50 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for CPAY just turned positive on October 15, 2026. Looking at past instances where CPAY's MACD turned positive, the stock continued to rise in 25 of 36 cases over the following month. The odds of a continued upward trend are 69%.
Following a +3.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPAY advanced for three days, in 234 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CPAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.348) is normal, around the industry mean (17.765). P/E Ratio (24.102) is within average values for comparable stocks, (159.605). Projected Growth (PEG Ratio) (0.757) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (5.528) is also within normal values, averaging (103.889).
Momentum Indicator for HCAT turns negative, indicating new downward trend
HCAT saw its Momentum Indicator move below the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In 83 of the 90 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 50-day moving average for HCAT moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
HCAT broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 64 cases where HCAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
HCAT moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HCAT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCAT advanced for three days, in 178 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 90 of 106 cases where HCAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.321) is normal, around the industry mean (7.432). HCAT has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
CPAY | HCAT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 44 | 100 | |
SMR RATING 1..100 | 33 | 99 | |
PRICE GROWTH RATING 1..100 | 41 | 56 | |
P/E GROWTH RATING 1..100 | 24 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCAT's Valuation (23) in the null industry is in the same range as CPAY (54) in the Miscellaneous Commercial Services industry. This means that HCAT’s stock grew similarly to CPAY’s over the last 12 months.
CPAY's Profit vs Risk Rating (44) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for HCAT (100) in the null industry. This means that CPAY’s stock grew somewhat faster than HCAT’s over the last 12 months.
CPAY's SMR Rating (33) in the Miscellaneous Commercial Services industry is significantly better than the same rating for HCAT (99) in the null industry. This means that CPAY’s stock grew significantly faster than HCAT’s over the last 12 months.
CPAY's Price Growth Rating (41) in the Miscellaneous Commercial Services industry is in the same range as HCAT (56) in the null industry. This means that CPAY’s stock grew similarly to HCAT’s over the last 12 months.
CPAY's P/E Growth Rating (24) in the Miscellaneous Commercial Services industry is significantly better than the same rating for HCAT (100) in the null industry. This means that CPAY’s stock grew significantly faster than HCAT’s over the last 12 months.
| CPAY | HCAT | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 68% | 1 day ago 70% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 69% | N/A |
| TrendWeek ODDS (%) | 1 day ago 70% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 58% | 1 day ago 88% |
| Advances ODDS (%) | 11 days ago 66% | 11 days ago 73% |
| Declines ODDS (%) | 5 days ago 67% | 4 days ago 87% |
| BollingerBands ODDS (%) | N/A | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 48% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CPAY’s FA Score shows that 2 FA rating(s) are green while HCAT’s FA Score has 1 green FA rating(s).
- CPAY’s FA Score: 2 green, 3 red.
- HCAT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CPAY’s TA Score shows that 3 TA indicator(s) are bullish while HCAT’s TA Score has 5 bullish TA indicator(s).
- CPAY’s TA Score: 3 bullish, 5 bearish.
- HCAT’s TA Score: 5 bullish, 4 bearish.
Price Growth
CPAY (@Computer Communications) experienced а +0.48% price change this week, while HCAT (@Services to the Health Industry) price change was -2.54% for the same time period.
The average weekly price growth across all stocks in the @Computer Communications industry was -8.82%. For the same industry, the average monthly price growth was -9.55%, and the average quarterly price growth was +0.53%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -4.54%. For the same industry, the average monthly price growth was -4.32%, and the average quarterly price growth was +10.20%.
Reported Earning Dates
CPAY is expected to report earnings on Nov 11, 2026.
HCAT is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Computer Communications (-8.82% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
@Services to the Health Industry (-4.54% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLDR | 49.98 | 0.06 | +0.12% |
| Fidelity Low Duration Bond Factor ETF (FLDR) | |||
| MYHB | 24.64 | -0.03 | -0.11% |
| State Street My2028 High Yield Corporate Bond ETF (MYHB) | |||
| FTBD | 47.30 | -0.06 | -0.14% |
| Fidelity Tactical Bond ETF (FTBD) | |||
| SBAR | 25.06 | -0.14 | -0.56% |
| Simplify Barrier Income ETF | |||
| AFSM | 39.03 | -0.61 | -1.54% |
| First Trust Active Factor Small Cap ETF (AFSM) | |||
CPAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, CPAY has been loosely correlated with HUBS. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CPAY jumps, then HUBS could also see price increases.
| Ticker / NAME | Correlation To CPAY | 1D Price Change % | ||
|---|---|---|---|---|
| CPAY | 100% | -1.57% | ||
| HUBS - CPAY | 63% Loosely correlated | -3.34% | ||
| SSNC - CPAY | 63% Loosely correlated | -0.14% | ||
| ADSK - CPAY | 62% Loosely correlated | -2.15% | ||
| CRM - CPAY | 61% Loosely correlated | -2.45% | ||
| PCOR - CPAY | 60% Loosely correlated | -2.76% | ||
More | ||||
HCAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.
| Ticker / NAME | Correlation To HCAT | 1D Price Change % | ||
|---|---|---|---|---|
| HCAT | 100% | -4.17% | ||
| KVYO - HCAT | 47% Loosely correlated | -5.58% | ||
| EVCM - HCAT | 46% Loosely correlated | -1.26% | ||
| RDVT - HCAT | 45% Loosely correlated | -4.11% | ||
| CPAY - HCAT | 43% Loosely correlated | -1.57% | ||
| COIN - HCAT | 43% Loosely correlated | -5.79% | ||
More | ||||